Kneat.com Inc (KSI) - Total Liabilities

Latest as of December 2025: CA$56.74 Million CAD ≈ $41.05 Million USD

Based on the latest financial reports, Kneat.com Inc (KSI) has total liabilities worth CA$56.74 Million CAD (≈ $41.05 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Kneat.com Inc - Total Liabilities Trend (2013–2025)

This chart illustrates how Kneat.com Inc's total liabilities have evolved over time, based on quarterly financial data. See KSI working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Kneat.com Inc Competitors by Total Liabilities

The table below lists competitors of Kneat.com Inc ranked by their total liabilities.

Company Country Total Liabilities
Tianjin Jieqiang Power Equipment Co
SHE:300875
China CN¥368.91 Million
Acacia Research Corporation
NASDAQ:ACTG
USA $188.65 Million
Huaren Pharmaceutical Co Ltd
SHE:300110
China CN¥1.86 Billion
AngioDynamics Inc
NASDAQ:ANGO
USA $87.32 Million
Deutsche Beteiligungs AG
XETRA:DBAN
Germany €207.06 Million
Three Stars NM
SHG:603578
China CN¥3.75 Billion
First Copper Technology Co Ltd
TW:2009
Taiwan NT$1.77 Billion
Gigasolar Materials
TWO:3691
Taiwan NT$5.37 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Kneat.com Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Kneat.com Inc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.82 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.87 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kneat.com Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kneat.com Inc (2013–2025)

The table below shows the annual total liabilities of Kneat.com Inc from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 CA$56.74 Million
≈ $41.05 Million
-4.65%
2024-12-31 CA$59.51 Million
≈ $43.05 Million
+19.65%
2023-12-31 CA$49.73 Million
≈ $35.98 Million
+103.60%
2022-12-31 CA$24.43 Million
≈ $17.67 Million
+42.89%
2021-12-31 CA$17.09 Million
≈ $12.37 Million
+17.18%
2020-12-31 CA$14.59 Million
≈ $10.55 Million
+320.65%
2019-12-31 CA$3.47 Million
≈ $2.51 Million
+37.54%
2018-12-31 CA$2.52 Million
≈ $1.82 Million
+634.81%
2017-12-31 CA$343.14K
≈ $248.22K
-84.97%
2016-12-31 CA$2.28 Million
≈ $1.65 Million
+287.09%
2015-12-31 CA$589.96K
≈ $426.77K
+270.96%
2014-12-31 CA$159.03K
≈ $115.04K
+10160.32%
2013-12-31 CA$1.55K
≈ $1.12K
--

About Kneat.com Inc

TO:KSI Canada Health Information Services
Market Cap
$447.84 Million
CA$619.09 Million CAD
Market Cap Rank
#13008 Global
#382 in Canada
Share Price
CA$6.44
Change (1 day)
+0.00%
52-Week Range
CA$3.30 - CA$6.44
All Time High
CA$7.16
About

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturin… Read more